Skip to main content
Glama

What's new in medtech

news
Read-onlyIdempotent

Use this when the user asks what's new in medtech, such as "any news in medtech", "what's new lately", "anything new in neuromodulation", "who got FDA clearance lately", "any recalls". The last days of sourced events at US medical device companies and their suppliers: FDA clearances and approvals, recalls and warning letters, device trials, funding and grants, press releases and hiring, one row per company with dates and source links, ranked for the rep's firm.

Input Schema

NameRequiredDescriptionDefault
askNoThe rep's question in their words.
daysNoHow many days back (default 7, up to 90).
aboutNoOptional: a device, technology or space, e.g. 'neuromodulation'.
limitNoCompanies per page (default 15, up to 100).
stateNoOptional US state name.
cursorNonext_cursor from the page before, for the next page.

Schema Changelog

Changes observed during successful MCP inspections.

  1. Changed2 schema fields changed
    • addedInput schema / properties / cursor
      Added value: +{
      +  "description": "next_cursor from the page before, for the next page.",
      +  "type": "string"
      +}
    • changedInput schema / properties / limit / description
      Previous value: -"Most companies to return (default 15, max 25)."New value: +"Companies per page (default 15, up to 100)."
  2. Added

TDQS

A4.1/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnly/idempotent/non-destructive, so the safety profile is covered; the description adds real value beyond that by disclosing the output shape (one row per company, with dates and source links), the ranking basis ('ranked for the rep's firm'), and the geographic scope (US). It omits pagination behavior and how ranking is computed, which keeps it from a 5.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The trigger condition is front-loaded in the first clause, and the second sentence packs scope, event taxonomy, and output shape efficiently. The quoted example list is somewhat long, but each example earns its place as a routing cue.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With six optional parameters, no output schema, and annotations covering safety, the description supplies the missing pieces an agent needs: what the rows contain, that results are ranked, and that coverage is US-only. Pagination is left entirely to the `cursor`/`limit` schema fields with no prose on paging behavior, a minor gap.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters3/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so all six parameters are already documented in the schema, and the description's example phrases ('anything new in neuromodulation', 'who got FDA clearance lately') loosely map to `about` and `days` without adding syntax or defaults. Baseline 3 is appropriate given the schema does the heavy lifting.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description names a specific resource and scope: recent sourced events at US medical device companies and their suppliers, covering FDA clearances, recalls, trials, funding, press and hiring, one row per company. This clearly distinguishes it from siblings like company, find, or about_the_data, which serve different lookup needs.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The opening clause gives an explicit trigger ('use this when the user asks what's new in medtech') followed by four concrete example utterances that cover common phrasings. There is no when-not guidance and no named alternative tool for adjacent questions (e.g., a specific company profile), so it stops short of a 5.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.